Osteobiologics

BACKGROUND: Osteobiologics are engineered materials that facilitate bone healing and have been increasingly used in spine surgery. Autologous iliac crest bone grafts have been used historically, but morbidity associated with graft harvesting has led surgeons to seek alternative solutions. Allograft bone, biomaterial scaffolds, growth factors, and stem cells have been explored as bone graft substitutes and supplements. OBJECTIVE: To review current and emerging osteobiologic technologies. METHODS: A literature review of English-language studies was performed in PubMed. Search terms included combinations of spine, fusion, osteobiologics, autologous, allogen(e)ic, graft, scaffold, bone morphogenic protein, and stem cells. RESULTS: Evidence supports allograft bone as an autologous bone supplement or replacement in scenarios where minimal autologous bone is available. There are promising data on ceramics and P-15; however, comparative human trials remain scarce. Growth factors, including recombinant human bone morphogenic proteins (rhBMPs) 2 and 7, have been explored in humans after successful animal trials. Evidence continues to support the use of rhBMP-2 in lumbar fusion in patient populations with poor bone quality or revision surgery, while there is limited evidence for rhBMP-7. Stem cells have been incredibly promising in promoting fusion in animal models, but human trials to this point have only involved products with questionable stem cell content, thereby limiting possible conclusions. CONCLUSION: Engineered stem cells that overexpress osteoinductive factors are likely the future of spine fusion, but issues with applying viral vector-transduced stem cells in humans have limited progress.

Automated summary

Osteobiologics are engineered materials used to facilitate bone healing in spine surgery, with options including allograft bone, biomaterial scaffolds, growth factors, and stem cells. While promising data exists from animal trials, comparative human trials remain limited.